Status:
WITHDRAWN
Pan-Cardio-Genetics Clot Assessment in Acute Coronary Syndromes
Lead Sponsor:
Aristotle University Of Thessaloniki
Collaborating Sponsors:
HELLENIC CENTER FOR MARINE RESEARCH
Harvard Medical School (HMS and HSDM)
Conditions:
STEMI - ST Elevation Myocardial Infarction
Thrombi
Eligibility:
All Genders
18+ years
Brief Summary
Acute myocardial infarction with ST elevation (STEMI) is one of the leading causes of mortality. Although the presence of thrombus in STEMI patients has been linked to adverse outcomes, routine thromb...
Eligibility Criteria
Inclusion
- Patients with symptoms of myocardial ischemia lasting for more than 30 minutes
- Definite ECG changes indicating STEMI
- Patients undergoing primary PCI within 12 hours from symptom onset
- Possibility to perform thrombus aspiration
- Written informed consent
Exclusion
- Treatment with fibrinolytic therapy for qualifying index STEMI event
- Patients with known intolerance to aspirin, ticagrelor or heparin
- Patients with active internal bleeding
- Patients with a recent history of intracranial hemorrhage
Key Trial Info
Start Date :
January 20 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03832153
Start Date
January 20 2019
End Date
March 30 2022
Last Update
March 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AHEPA University Hospital
Thessaloniki, Greece, 54636